trial · primary record
177Lu-P17-088
Prostate Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 25 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Prostate-specific antigen 50 (PSA50) response |
| Registry ID | NCT07562438 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:12.660Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07562438
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.